Literature DB >> 8277183

Primary influenza A virus infection induces cross-reactive antibodies that enhance uptake of virus into Fc receptor-bearing cells.

R Gotoff1, M Tamura, J Janus, J Thompson, P Wright, F A Ennis.   

Abstract

Sera of young children who had had a primary infection with influenza A virus or were immunized with a live attenuated influenza A virus vaccine were examined for antibody responses that neutralized virus or enhanced uptake of virus into Fc receptor-bearing cells, because antibodies that enhance uptake of influenza virus into Fc receptor-bearing cells have been reported using mouse immune serum and monoclonal antibodies. The neutralizing antibody titers to the homologous infecting virus and to another H1N1 virus isolated several years later were higher after natural infection than after infection with the live attenuated virus. Natural infection and the attenuated vaccine induced antibodies that enhanced uptake of homologous virus and H1N1 virus isolated several years later. These results demonstrate that primary influenza A virus infection results in the induction of infection-enhancing antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8277183     DOI: 10.1093/infdis/169.1.200

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

Review 1.  Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.

Authors:  Von Vergel L Torres; Carrie F Coggon; Timothy J Wells
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

2.  Vaccine-Associated Enhanced Respiratory Disease following Influenza Virus Infection in Ferrets Recapitulates the Model in Pigs.

Authors:  J Brian Kimble; Meghan Wymore Brand; Bryan S Kaplan; Phillip Gauger; Elizabeth M Coyle; Katarina Chilcote; Surender Khurana; Amy L Vincent
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

3.  Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses.

Authors:  M Tamura; R G Webster; F A Ennis
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Natasha S Crowcroft; Naveed Z Janjua; Nicole Boulianne; Travis S Hottes; Laura C Rosella; James A Dickinson; Rodica Gilca; Pam Sethi; Najwa Ouhoummane; Donald J Willison; Isabelle Rouleau; Martin Petric; Kevin Fonseca; Steven J Drews; Anuradha Rebbapragada; Hugues Charest; Marie-Eve Hamelin; Guy Boivin; Jennifer L Gardy; Yan Li; Trijntje L Kwindt; David M Patrick; Robert C Brunham
Journal:  PLoS Med       Date:  2010-04-06       Impact factor: 11.069

5.  Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells.

Authors:  Ramil Sapinoro; Ketna Volcy; W W Shanaka I Rodrigo; Jacob J Schlesinger; Stephen Dewhurst
Journal:  Virology       Date:  2008-01-14       Impact factor: 3.616

6.  Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV).

Authors:  Danuta M Skowronski; Suzana Sabaiduc; Siobhan Leir; Caren Rose; Macy Zou; Michelle Murti; James A Dickinson; Romy Olsha; Jonathan B Gubbay; Matthew A Croxen; Hugues Charest; Nathalie Bastien; Yan Li; Agatha Jassem; Mel Krajden; Gaston De Serres
Journal:  Euro Surveill       Date:  2019-11

7.  Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19.

Authors:  Francesco Pinotti; Paul S Wikramaratna; Uri Obolski; Robert S Paton; Daniel S C Damineli; Luiz C J Alcantara; Marta Giovanetti; Sunetra Gupta; José Lourenço
Journal:  BMC Med       Date:  2021-01-12       Impact factor: 8.775

8.  Randomized controlled ferret study to assess the direct impact of 2008-09 trivalent inactivated influenza vaccine on A(H1N1)pdm09 disease risk.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Gaston De Serres; Naveed Z Janjua; Guiyun Li; Suzana Sabaiduc; Xavier Bouhy; Christian Couture; Anders Leung; Darwyn Kobasa; Carissa Embury-Hyatt; Erwin de Bruin; Robert Balshaw; Sophie Lavigne; Martin Petric; Marion Koopmans; Guy Boivin
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 9.  Fc receptors in antibody-dependent enhancement of viral infections.

Authors:  Adam Taylor; Suan-Sin Foo; Roberto Bruzzone; Luan Vu Dinh; Nicholas J C King; Suresh Mahalingam
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.